Tom Mueller addresses lessons learned around global clinical trial supply chains as well as trends to watch for going forward.

Scott Scarola speaks to the trend of DCTs as well as how COVID-19 has changed the industry’s approach toward clinical trials.

Geoffrey Gill talks to the potential of wearables to improve clinical research and how barriers to adoption can be overcome.

Rod Walker talks to the importance of diversity in clinical research, what changes need to happen, and what progress looks like.

John Reites discusses DCTs evolution to make clinical research more inclusive and accessible and what organizations need to do to make the transition to a hybrid model successfu

Jonathan Burr identifies emerging categories of AI to inform clinical trials of the future and how AI analytics can be applied to better inform decisions.

In light of evolving clinical trial technology, Jason Casarella talks about the skills that will be needed as the industry moves into the next phase of adoption.

As sponsors consider DCT approaches to make clinical trials more patient-centric, Ronan Brown, outlines best practices to get started and how to measure ROI.

Dr. Zabinski addresses the use of AI as well as examples of quick wins when AI is applied in the life sciences.

Kyle Hogan links the connection between behavioral science and eCOA, patient engagement, and clinical trials at large.

Ed Seguine identifies areas of importance to consider when thinking about patients and sites in totality as well as how technology can support complex protocol design.

Joe Eazor speaks to the merger of two best-in-class companies and what this means for patients as well as customers.

PharmaVOICE sat down with Dr. Susan Galbraith, SVP of Early Oncology, AstraZeneca, who disclosed her personal career journey with oncology and drug development as she works to improve patients’ lives.

Dan Wilmer, Executive Vice President and Chief Product Officer, InStep Health talks about the positive impact that digital tools and solutions are having on patients with Taren Grom from PharmaVOICE.

Brigham Hyde, President, Data & Analytics, EVERSANA talks about supporting organizations to adapt to an evolving digital transformation with Taren Grom from PharmaVOICE.

Kathleen Mandziuk, MPH, RN, PRA Health Sciences, talks about a data-led 360º patient view and data-driven decision-making with Taren Grom from PharmaVOICE. Other videos in the series: Part 2: Better Patient Journey Part 3: Clinical Research Simplified

Christina Fawcett, PRA Health Sciences, talks about patient-centric trial design and creating a better overall patient journey pathway with Taren Grom from PharmaVOICE. Other videos in the series: Part 1: A Data Led Approach Part 3: Clinical Research Simplified

Marcus Grindstaff, PRA Health Sciences, talks about integrating fit-for-purpose technology into the trial to simplify clinical research with Taren Grom from PharmaVOICE. Other videos in the series: Part 1: A Data Led Approach Part 2: Better Patient Journey

Dinesh Kasthuril, Covance, talks about pharmacovigilance and the future of safety data and the role of technology with Taren Grom from PharmaVOICE.

J.P. Maranzani, Ogilvy Health, talks about ways in which marketers can use AI to make brands more successful with Taren Grom from PharmaVOICE.

Roshawn Blunt, 1798, a Fingerpaint company, talks about the unique commercialization challenges gene and cell therapy companies face with Taren Grom from PharmaVOICE.

Bryan O’Malley & Nick Bartolomeo, co-leads of Fingerpaint’s Shift Performance Center of Excellence, talk about the influence of data on healthcare marketing with Taren Grom from PharmaVOICE.

Malai Sankarasubbu, Saama Technologies, talks about optimizing AI to improve clinical trials with Taren Grom from PharmaVOICE.

Rich Christie, M.D., Ph.D., AiCure, talks about the adoption of technology to improve the clinical trial process with Taren Grom from PharmaVOICE.

Maria Kirsch, EVERSANA, talks about the biggest trends in patient services with Taren Grom from PharmaVOICE.

Matthew Van Wingerden, Aktana, talks about using AI effectively to solve major challenges with Taren Grom from PharmaVOICE.

Claire Bonaci, Microsoft, talks about how AI collaborations are transforming the life-sciences industry with Taren Grom from PharmaVOICE.

Max Divak, Ogilvy Health, talks about the ways AI can be used to augment brand/company messaging with Taren Grom from PharmaVOICE.

Amrita Bhowmick, Health Union, talks about ways to leverage social media to help combat social isolation with Taren Grom from PharmaVOICE.

Gregory Skalicky, EVERSANA, talks about commercial support for small to mid-tier innovative companies with Taren Grom from PharmaVOICE.

Gregory T. Simpson, VP and Head of Marketing, Saama Technologies, talks to the importance of remote monitoring to improve a clinical trial and accelerate outcomes and what sponsors need to consider when looking for a remote monitoring program.

Richard Gliklich, M.D., CEO, OM1, discusses the special considerations and challenges around quality in clinical data in terms of regulatory considerations as well as how AI and machine learning factor into R&D today and in the future.

Chris Benko, CEO, Koneksa, speaks to the current regulatory climate surrounding digital biomarkers and illustrates the potential of this technology.

MaryAnne Rizk, Ph.D., Senior VP, Digital R&D Strategy, IQVIA, examines how increased virtuality and digitization will lead to a new era of patient care and how making clinical development part of patient care can change the trajectory of health outcomes.

Erica Prowisor, Global Head, Recruitment & Retention, IQVIA, explores the impact of COVD-19 on patient recruitment and what the future holds in terms of a more holistic human-centered approach to recruiting.

Elisa Cascade, Executive VP of eCOA, ERT, talks about the impact that COVID-19 is having on clinical trial data collection and the technical advances ERT offers to help facilitate remote data capture to keep clinical trials on track.

Raj Indupuri, CEO, eClinical Solutions, previews his 2020 DIA session addressing the key uses of AI in the data review process as well as how AI can transform data management.

Andrew Schachter, CEO and Founder, Axiom Real-Time Metrics Inc., outlines the importance of a unified platform to the success of clinical trials in today’s environment.

Jason Casarella, Executive VP, Business Development & Marketing, Advanced Clinical, discusses the opportunities to improve clinical research presented by the global pandemic and what a return to “normal” might look like.

Michael O’Gorman, CEO & Founder, Life Science Marketplace, discusses industry trends impacting clinical trials amid the COVID-19 pandemic.

In this Editor’s Take Video, Dan Limbach, producer of the PharmaVOICE Webcast Network, meets with WCG’s Jill Johnston to talk about the optimum clinical trial site activation process, overcoming the key challenges to getting there, and empowering the team responsible for thi … Read More »

In this Editor’s Take Video, Dan Limbach, producer of the PharmaVOICE Webcast Network, meets with Larissa Comis to talk about Cognizant’s Shared Investigator Platform in its current form, and how it will look in the future, at the 2020 SCOPE Conference.

In this Editor’s Take Video, Dan Limbach, producer of the PharmaVOICE Webcast Network, meets with Nagaraja Srivatsan to talk about the role of the chief digital officer in life-sciences companies, IQVIA’s current and next-generation clinical stack, and how this technology de … Read More »

In this Editor’s Take Video, Dan Limbach, producer of the PharmaVOICE Webcast Network, meets with Andy Greenberg to talk about changing client needs in the liife-sciences industry, as well as the primary obstacles to broader adoption of digital technologies in clinical trial … Read More »

In this Editor’s Take Video, Dan Limbach, producer of the PharmaVOICE Webcast Network, meets with Tyler Pugsley to talk about Medable’s Patient Advisory Council, and why it is so important to involve patients earlier in the R&D process, at the 2020 SCOPE Conference.

In this Editor’s Take Video, Dan Limbach, producer of the PharmaVOICE Webcast Network, meets with AiCure’s Michelle Marlborough and Lauren Sunshine to talk about how AI can improve clinical trials success rates, increase patient engagement, improve clinical outcomes, and boo … Read More »

In this Editor’s Take video, Taren Grom, Editor of PharmaVOICE, is at the 2019 World Congress Copay Summit in Alexandria, Virginia. She meets with Jason Zemcik and Rick Fry from TrialCard to talk about managing risk and mitigating fraud within copay support programs.

In this Editor’s Take video, Taren Grom, Editor of PharmaVOICE, is at the 2019 World Congress Copay Summit in Alexandria, Virginia. She meets with Paul LeVine, representing Mango Health, a TrialCard company. They talk about copay programs and their importance to a brand’s ma … Read More »

Mark Miller talks about how marketing and technology are partnering to improve human experiences, and how Customer Experience (CX) Centers of Excellence (COE) are driving these advancements.

David Shronk describes how online health communities can improve the patient experience and deliver value to pharmaceutical companies.

Bryan O’Malley discusses using digital tools for improving the brand experience, integrating the patient experience within a digital marketing strategy, and when to incorporate digital into the creative process in marketing.

Jason Casarella imagines an R&D ecosystem where barriers and labels were eliminated and we could all work together as one community. He also shares the importance of learning every day, and how even failure in clinical research provides valuable information and knowledge … Read More »

Peyton Howell talks about what it would be like if we focused on bringing new treatments to patients using new, daring, and bold ideas. Filmed at the 2019 DIA Annual Conference in San Diego, CA.

Craig Lipset discusses his career highlights working on the clinical research service provider side as well as within large pharma, and how the industry can evolve and raise the bar in clinical research using new technologies and processes. Filmed at the 2019 DIA Annual Conf … Read More »

Sheila Mahoney-Jewels discusses her “Imagine if” scenario about a single place to find the right independent consultant who can be onboarded immediately for a specific amount of time over the course of a project. Filmed at the 2019 DIA Annual Conference in San Diego, CA.

Bruce Hellman imagines what would be possible if every person was a happily engaged research participant. Filmed at the 2019 DIA Annual Conference in San Diego, CA.

Andrew Schachter explains how sponsors can us technology to achieve trial objectives more quickly and easily even as clinical research becomes increasingly complex and as FDA regulations demand more accountability.

Marc Hoffman and Steve Clemons discuss the prevalence of COPD as the third-leading cause of death and how their two companies are collaborating to bring new biomarkers to sponsors and CROs to address this health crisis.

Tanya du Plessis discusses why the increased adoption of new solutions, including medical and consumer-grade technologies, changed data collection / management processes and the role of data managers.

Dr. MaryAnne Rizk discusses one of the hottest topics of the moment: the digital transformation of R&D. She explains how an end-to-end patient-centric cloud platform can provide the needed orchestration.

Joel Selzer discusses his company’s unique approach to measuring and analyzing behavioral insights from clinicians based on their interactions with educational and training content.

Eleanor Doyle talks about the evolution of FSP (functional service outsourcing) and how Syneos Health’s FSP 360 model is driving speed, quality, and efficiencies for customers.

Joe Ehrline talks about the opportunities and benefits that life-science companies can gain by effectively employing data analytics as part of a comprehensive strategy to accelerate drug development.

Bruce Palsulich discusses the impact AI will have on pharmacovigilance as well as other aspects of clinical trials and the industry at large.

Josh Rose discusses the coming of age of virtual trials and what sponsors need to know as they strategically evaluate this clinical model.

Dr. Deieso and Ms. Williams discuss patient centricity in clinical development and ways to improve the patient experience.

Wenda Brennan discusses important areas in adverse event reporting, and trends in pharmacovigilance.

Cat Hall discusses the next priorities for technology advancement in helping to manage clinical trials and what future customer needs will need to be met.

Raj Indupuri of eClinical Solutions talks about the need for companies to transform their processes and adopt digital clinical capabilities and how to overcome current obstacles to achieve better outcomes.

Karin Beckstrom discusses the opportunities that virtual trials can bring to the clinical trial ecosystem and to patients as well.

Mike Nolte talks about Signant’s new brand and the importance of bringing empathy into clinical trials.

Evgenia Mikhalchuk and Yvonne Lungershausen discuss the best practices for selecting the right clinical software provider and the benefits that a solid partnership provide to both entities.

Jason Casarella talks about why it’s important for companies to embrace E6 (R2), which provides a unified standard for the European Union, Japan, and the United States to facilitate the mutual acceptance of clinical data by the regulatory authorities in these jurisdictions.

Larissa Comis discusses How Cognizant Shared Investigator Platform is reducing the administrative burden on sites and why organizational change management is so important for success.

Dr. Michelle Longmire, CEO of Medable, talks about the value of eCOA and why it’s important to integrate data to improve the patient experience as part of participating in a clinical trial.